ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "#100 – Tackling Tetracyclines: Breakpoints 100th Episode!"
Episode Synopsis
Drs. Jeffrey Pearson and Jason Pogue join Dr. Jeannette Bouchard as they take on all things tetracyclines. Starting with tetracycline, they walk through differences between each generation and drug in this class, from dosing all the way to pertinent resistance mechanisms. You will not want to miss out on this one! This podcast was supported by an unrestricted grant from Paratek Pharmaceuticals Inc.
References:
Omadacycline for Mycobacterium abscessus full case series data set: 10.1128/aac.00824-23
Long term safety of omadacycline in Mycobacterium abscessus: 10.1093/ofid/ofad335
USCAST Acinetobacter baumannii Recommendations for Susceptibility Test Interpretive Criteria: https://www.uscast.org/uploads/1/1/9/0/119044870/uscast_alepak_acbc_stic_08feb23.pdf
References:
Omadacycline for Mycobacterium abscessus full case series data set: 10.1128/aac.00824-23
Long term safety of omadacycline in Mycobacterium abscessus: 10.1093/ofid/ofad335
USCAST Acinetobacter baumannii Recommendations for Susceptibility Test Interpretive Criteria: https://www.uscast.org/uploads/1/1/9/0/119044870/uscast_alepak_acbc_stic_08feb23.pdf
More episodes of the podcast Breakpoints
#128 – IDWeek 2025 Recap
19/12/2025
#124 – Dosing Consult: Cefepime
10/10/2025
In God we trust